Penserra Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.07 - $5.3 $4,517 - $5,883	-1,110 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $188 - $289	40 Added 3.74%	1,110 $5,000
Q2 2021 Aug 12, 2021	BUY	$6.81 - $10.93 $136 - $218	20 Added 1.9%	1,070 $7,000
Q4 2020 Feb 12, 2021	BUY	$4.58 - $7.14 $4,809 - $7,497	1,050 New	1,050 $6,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.